Aridis Pharmaceuticals (ARDS) Short Interest Ratio & Short Volume $0.0001 0.00 (0.00%) As of 08/4/2025 02:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock Aridis Pharmaceuticals Short Interest DataAridis Pharmaceuticals (ARDS) has a short interest of 21,700 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 3.2, indicating that it would take 3.2 days of the average trading volume of 8,993 shares to cover all short positions.Current Short Interest21,700 sharesPrevious Short Interest21,700 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$2.17Short Interest Ratio3.2 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares53,321,000 sharesPercentage of Shares Shorted0.04%Today's Trading Volume1,505 sharesAverage Trading Volume8,993 sharesToday's Volume Vs. Average17% Short Selling Aridis Pharmaceuticals? Sign up to receive the latest short interest report for Aridis Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartARDS Short Interest Over TimeARDS Days to Cover Over TimeARDS Percentage of Float Shorted Over Time Aridis Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202521,700 shares $2.17 No ChangeN/A3.2 $0.00 6/30/202521,700 shares $2.17 +1,176.5%0.0%0.8 $0.00 6/15/20251,700 shares $0.17 No Change0.0%0.2 $0.00 5/31/20251,700 shares $0.17 No Change0.0%0.2 $0.00 5/15/20251,700 shares $0.17 No ChangeN/A0.3 $0.00 4/30/20251,700 shares $0.00 No ChangeN/A0.4 $0.00 4/15/20251,700 shares $0.17 No ChangeN/A0.4 $0.00 3/14/20251,700 shares $0.17 No ChangeN/A1.7 $0.00 2/28/20251,700 shares $0.17 No ChangeN/A0.1 $0.00 2/14/20251,700 shares $0.17 No ChangeN/A1.5 $0.00 Get the Latest News and Ratings for ARDS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aridis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20251,700 shares $17.00 No ChangeN/A0.1 $0.01 1/15/20251,700 shares $0.17 No ChangeN/A0.1 $0.00 7/15/20232,430,000 shares $774.93 thousand +21.5%N/A0.5 $0.32 6/30/20232,000,000 shares $439.80 thousand +8.1%N/A0.6 $0.22 6/15/20231,850,000 shares $499.32 thousand +320.7%N/A0.5 $0.27 5/31/2023439,700 shares $174.74 thousand -41.9%N/A0.1 $0.40 5/15/2023756,200 shares $161.22 thousand +87.0%N/A0.9 $0.21 4/30/2023404,400 shares $72.71 thousand -29.5%N/A0.4 $0.18 4/15/2023573,300 shares $126.13 thousand +0.3%N/A0.4 $0.22 3/31/2023571,400 shares $179.48 thousand -81.3%N/A0.4 $0.31 3/15/20233,060,000 shares $1.27 million +323.8%N/A2 $0.41 2/28/2023722,100 shares $407.26 thousand +2.6%N/A0.8 $0.56 2/15/2023703,900 shares $436.42 thousand +7.6%N/A0.8 $0.62 1/31/2023654,300 shares $438.38 thousand +1,125.3%N/A0.8 $0.67 1/15/202353,400 shares $68.09 thousand -44.3%N/A0.2 $1.28 12/30/202295,900 shares $113.16 thousand -51.1%N/A0.9 $1.18 12/15/2022196,200 shares $198.16 thousand +120.0%N/A1.2 $1.01 11/30/202289,200 shares $81.17 thousand -8.0%N/A0.6 $0.91 11/15/202297,000 shares $81.48 thousand -7.6%N/A0.7 $0.84 10/31/2022105,000 shares $109.20 thousand -49.8%N/A0.7 $1.04 10/15/2022209,000 shares $204.90 thousand -55.9%N/A1 $0.98 9/30/2022473,500 shares $440.36 thousand +276.7%N/A2.3 $0.93 9/15/2022125,700 shares $227.52 thousand +42.2%N/A1.1 $1.81 8/31/202288,400 shares $129.06 thousand -53.4%N/A0.7 $1.46 8/15/2022189,700 shares $415.44 thousand +53.2%N/A1.5 $2.19 7/31/2022123,800 shares $305.79 thousand +28.0%N/A1 $2.47 7/15/202296,700 shares $106.37 thousand +3.5%N/A1.8 $1.10 6/30/202293,400 shares $102.74 thousand -50.2%N/A1.7 $1.10 6/15/2022187,700 shares $268.41 thousand +0.9%N/A2.9 $1.43 5/31/2022186,000 shares $213.90 thousand +114.5%N/A2.6 $1.15Elon’s NEXT Big IPO? (Ad)Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it takes for the entire thing to burn right up. It’s a NEW internet service poised to disrupt the entire $3.2 trillion telecom industry. But you may only have this chance if you act before December 31st, 2025.One that experts predict could be worth over $3.2 TRILLION globally by 2030. 5/15/202286,700 shares $80.89 thousand -20.8%N/A0.6 $0.93 4/30/2022109,500 shares $136.88 thousand +52.1%N/A0.3 $1.25 4/15/202272,000 shares $103.68 thousand -36.3%N/A0.1 $1.44 3/31/2022113,000 shares $198.88 thousand +32.0%1.2%0.1 $1.76 3/15/202285,600 shares $130.11 thousand -55.0%0.9%0 $1.52 2/28/2022190,000 shares $380 thousand -77.5%2.0%0.1 $2.00 2/15/2022844,900 shares $2.07 million -67.6%8.9%0.4 $2.45 1/31/20222,610,000 shares $4.72 million +1,272.2%27.6%1.2 $1.81 1/15/2022190,200 shares $292.91 thousand +45.9%2.0%0.1 $1.54 12/31/2021130,400 shares $303.83 thousand +3,004.8%1.4%0.1 $2.33 12/15/20214,200 shares $9.16 thousand -82.1%0.0%0 $2.18 11/30/202123,500 shares $53.11 thousand +360.8%0.3%0.7 $2.26 11/15/20215,100 shares $14.23 thousand -67.1%0.1%0.2 $2.79 10/29/202115,500 shares $54.25 thousand -49.7%0.2%0.4 $3.50 10/15/202130,800 shares $108.42 thousand -53.5%0.4%0.5 $3.52 9/30/202166,200 shares $243.62 thousand +13.0%0.9%0.4 $3.68 9/15/202158,600 shares $234.40 thousand -0.9%0.8%0.4 $4.00 8/31/202159,100 shares $237.58 thousand +7.1%0.8%0.4 $4.02 8/13/202155,200 shares $212.52 thousand +38.7%0.8%0.3 $3.85 7/30/202139,800 shares $198.60 thousand +54.9%0.6%0.3 $4.99 7/15/202125,700 shares $147.00 thousand +10.8%0.3%0.2 $5.72 6/30/202123,200 shares $171.68 thousand +35.7%0.3%1 $7.40 6/15/202117,100 shares $123.46 thousand +11.8%0.2%0.9 $7.22 5/28/202115,300 shares $88.43 thousand -32.3%0.2%0.6 $5.78 5/14/202122,600 shares $141.25 thousand +43.0%0.3%0.8 $6.25 4/30/202115,800 shares $98.50 thousand -8.7%0.2%0.5 $6.23 4/15/202117,300 shares $101.03 thousand -22.8%0.2%0.5 $5.84 3/31/202122,400 shares $128.80 thousand +63.5%0.3%0.7 $5.75 3/15/202113,700 shares $105.76 thousand +61.2%0.2%0.5 $7.72 2/26/20218,500 shares $52.36 thousand -30.9%0.1%0.4 $6.16 2/12/202112,300 shares $97.79 thousand +66.2%0.2%0.6 $7.95 1/29/20217,400 shares $48.77 thousand -9.8%0.1%0.5 $6.59 1/15/20218,200 shares $57.24 thousand +64.0%0.1%0.6 $6.98 12/31/20205,000 shares $30.55 thousand -12.3%0.1%0.4 $6.11 12/15/20205,700 shares $43.78 thousand -31.3%0.1%0.5 $7.68 11/30/20208,300 shares $56.68 thousand -27.8%0.1%0.7 $6.83 11/15/202011,500 shares $81.65 thousand +38.6%0.2%1 $7.10 10/30/20208,300 shares $53.78 thousand -83.2%0.1%0.7 $6.48 10/15/202049,400 shares $366.55 thousand -17.3%0.8%4.3 $7.42 9/30/202059,700 shares $422.68 thousand +911.9%1.2%5.3 $7.08 9/15/20205,900 shares $42.95 thousand -45.4%0.1%0.5 $7.28 8/31/202010,800 shares $75.60 thousand -57.7%0.2%1 $7.00 8/14/202025,500 shares $163.46 thousand -3.0%0.5%2.5 $6.41 ARDS Short Interest - Frequently Asked Questions What is Aridis Pharmaceuticals' current short interest? Short interest is the volume of Aridis Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 21,700 shares of ARDS short. Learn More on Aridis Pharmaceuticals' current short interest. What is a good short interest ratio for Aridis Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ARDS shares currently have a short interest ratio of 3.0. Learn More on Aridis Pharmaceuticals's short interest ratio. How does Aridis Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Aridis Pharmaceuticals: Smart for Life, Inc. (0.01%), Scopus BioPharma Inc. (0.02%), Evelo Biosciences, Inc. (0.04%), Comera Life Sciences Holdings, Inc. (0.01%), Genocea Biosciences, Inc. (0.33%), Statera Biopharma, Inc. (0.15%), Ampio Pharmaceuticals, Inc. (0.01%), eFFECTOR Therapeutics, Inc. (0.12%), Clever Leaves Holdings Inc. (0.48%), OncoSec Medical Incorporated (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Aridis Pharmaceuticals stock? Short selling ARDS is an investing strategy that aims to generate trading profit from Aridis Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aridis Pharmaceuticals? A short squeeze for Aridis Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ARDS, which in turn drives the price of the stock up even further. How often is Aridis Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARDS, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies Smart for Life Short Interest Scopus BioPharma Short Interest Evelo Biosciences Short Interest Comera Life Sciences Short Interest Genocea Biosciences Short Interest Statera Biopharma Short Interest Ampio Pharmaceuticals Short Interest eFFECTOR Therapeutics Short Interest Clever Leaves Short Interest OncoSec Medical Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ARDS) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredGuess Who the Gvt Could Partner With Next?The Government Just Made a $400M Bet. Who's Next? A $100 trillion wealth shift is quietly underway... and t...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredInstant Cash (every 3rd Monday)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aridis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aridis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARDS Stock Alerts